Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus-Reference-Cited by-同舟云学术

Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus

Published:2023-07 Issue:1 Volume:89 Page:171-173
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Chasset François,Jaume Léa,Mathian Alexis,Abisror Noémie,Dutheil Amélie,Barbaud Annick,Kottler Diane,Girard Céline,Jousse-Joulin Sandrine,Tauber Marie,Livideanu Cristina Bulai,Avettand-Fenoel Véronique,Lhote Raphael,Pha Micheline,Amoura Zahir

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Trial of anifrolumab in active systemic lupus erythematosus;Morand;N Engl J Med,2020

2. Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial;Furie;Lancet Rheumatol,2019

3. Anifrolumab for treatment of refractory cutaneous lupus erythematosus;Blum;Clin Exp Dermatol,2022

4. The CLASI (Cutaneous LE Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus;Albrecht;J Am Acad Dermatol,2005

5. Combined oral contraceptives in women with systemic lupus erythematosus;Petri;N Engl J Med,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab;Journal of the European Academy of Dermatology and Venereology;2024-08-13

2. Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients;Lupus;2024-08-04

3. Exploring New Frontiers: Innovations and Therapeutic Targets in Dermatology;International Journal of Molecular Sciences;2024-07-25

4. Novedades en la inmunoterapia de las enfermedades autoinmunes del tejido conectivo. Parte I: lupus eritematoso cutáneo;Piel;2024-07

5. Uso del anifrolumab en el lupus eritematoso sistémico, lupus eritematoso cutáneo y otras dermatosis autoinmunes;Actas Dermo-Sifiliográficas;2024-07